Fennec Pharmaceuticals Inc. (FENC) Stock

Fennec Pharmaceuticals Inc. (FENC) is a Healthcare stock trading at $9.05 (as of 2026-06-18), with a market capitalization of $335.21M and a trailing P/E of -31.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Fennec Pharmaceuticals Inc. is a biopharmaceutical company with PEDMARK, a clinical-stage formulation of sodium thiosulfate intended to help prevent platinum-induced ototoxicity in pediatric cancer patients. The company is based in Research Triangle Park, North Carolina.

Valuation — source: SEC EDGAR (first-party)
Price$9.05
Market Cap$335.21M
P/E Ratio-31.2
Price / Book8.35
Price / Sales6.17
DCF Value (model)$-5.09
DCF Upside vs Price-156.2%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$44.64M
Net Margin-21.8%
Return on Equity-22.2%
Debt / Equity0.51
Current Ratio6.98
Revenue Growth (YoY)-6.1%
EPS Growth (YoY)1600.0%
Financial Health — source: SEC EDGAR
Altman Z-Score2.08 (grey)
Valuation vs Sector & Industry
Stock P/E-31.2
Sector P/E (Healthcare)20.9
Industry P/E (Pharmaceutical Products)17.0
vs Sector-249.6%
vs Industry-283.6%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderRosalind Advisors, Inc. ($17.89M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOJeffrey S. Hackman
Employees32
CountryUS
IPO Date2017-09-15

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Immuneering Corporation (IMRX)
  • Aardvark Therapeutics, Inc. Common Stock (AARD)
  • Protara Therapeutics, Inc. (TARA)
  • Atea Pharmaceuticals, Inc. (AVIR)
  • Immix Biopharma, Inc. (IMMX)
  • Inhibikase Therapeutics, Inc. (IKT)
  • Galectin Therapeutics Inc. (GALT)
  • Heron Therapeutics, Inc. (HRTX)
FENC earnings history · FENC institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.